Tumour cell lines | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
CAN genes | 1039 | 1076 Diff CSC | 1247 Diff CSC | 1546 | 1869 | 1872 | 21 052 | 23 873 | ||
APC | S1395fs*2 | V915fs*2 | V915fs*2 | R1114*d (44%)e R1450* (52%) R2204* (33%) A2650V (58%) | R1114* (44%) R1450* (52%) R2204* (33%) A2650V (58%) | Q1328* | E1317fs*3 | E893* | ||
KRAS | G12D | G12D | G12D | Q61L | G13D | G12D | G12C | G13D | ||
TP53 | Y107D | R248W | R248W | R175H | R175H | R248Q | R158L | |||
PIK3CA | Q546K | R770Q | R770Q | E545K | ||||||
FBXW7 | R479Q | H379Y | ||||||||
CSMD3 | L2424fs*9 | |||||||||
TNN | ||||||||||
NAV3 | ||||||||||
SMAD4 | V370A/E41* | V370A/E41* | R361C | S325P | ||||||
EPHA3 | ||||||||||
MAP2K7 | ||||||||||
EPHRB6 | 173insSS | C316Y | C316Y | |||||||
PTEN | ||||||||||
ADAMTSL3 | ||||||||||
GUCY1A2 | ||||||||||
SMAD2 | G457* | |||||||||
OR51E1 | ||||||||||
LAMA1 | ||||||||||
C10orf137 | S168L | S168L | ||||||||
TCF7L2 | P477T | P477T |
*d, nonsense mutation introducing stop codon; e (percentage of variation), indicated the frequency of cDNA reads containing the mutation encoding the reported protein sequence, determined on all the APC cDNA sequences obtained.
APC, antigen presenting cells; CSC, cancer stem/initiating cell cultures; CRC, colorectal cancers; Diff, differentiated cancer cell lines; fs*, frameshift mutation followed by nucleotide number before stop codon.